Target intelligence / Profile preview

Off-target messenger RNAs with seed-region complementarity

Molecular classification
Messenger RNA, Nucleic acid
01

Overview

Off-target messenger RNAs with seed-region complementarity represent a major class of unintended targets for RNA interference (RNAi) therapeutics, such as small interfering RNAs (siRNAs). This phenomenon occurs when the seed region of an siRNA guide strand—typically nucleotides 2 through 8—binds to complementary sequences in the 3' untranslated regions (UTRs) of non-target mRNAs (Jackson et al., 2003; Birmingham et al., 2006). This interaction mimics the natural regulatory mechanism of microRNAs (miRNAs), leading to the unintended downregulation of numerous genes across the transcriptome. Such off-target effects are a significant concern in drug development as they can lead to cellular toxicity, altered biological pathways, and adverse clinical outcomes. Modern siRNA design strategies, including chemical modifications like 2'-O-methyl substitutions at position 2 of the guide strand, are employed to destabilize these off-target interactions while maintaining on-target potency (Jackson et al., 2006; Janas et al., 2018).

Other names
Seed-mediated off-targetsmiRNA-like off-target effectssiRNA off-target mRNAsOff-target transcripts
02

Mechanism of action

Unintended binding of the siRNA guide strand seed region (nucleotides 2-8) to partially complementary sequences in the 3' UTR of non-target mRNAs, leading to RISC-mediated silencing (Jackson et al., 2003).

03

Biological functions

Gene expression regulationmRNA degradationTranslational repression
04

Disease associations

Drug-induced toxicityAdverse drug reactions
05

Safety considerations

HepatotoxicityOff-target gene silencingCellular toxicityUnintended phenotypic changesSaturation of RNAi machinery
06

Interacting drugs

Patisiran

5 more in the full profile.

07

Biomarkers

RNA-seqTranscriptome-wide expression profilingReporter gene assays

Beyond the preview

Go deeper on Off-target messenger RNAs with seed-region complementarity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Off-target messenger RNAs with seed-region complementarity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call